News & Updates
Filter by Specialty:
Risk downgrade common in GGG3 prostate cancer patients with single positive biopsy core
13 Feb 2022
In Gleason grade group (GGG) 3 prostate cancer patients with a single intermediate-risk positive biopsy core, risk downgrading appears to be more likely than upgrading, reports a new study.
Risk downgrade common in GGG3 prostate cancer patients with single positive biopsy core
13 Feb 2022Recurrent node-positive breast cancer reveals distant metastasis in patients
12 Feb 2022
Distant metastasis is present in all patients with node-positive breast cancer (NPBC) at the time of recurrence, reveals a study. Compared with diffusely metastatic (DM) patients, those with oligometastasis (OM) have shorter time to recurrence but longer overall survival (OS).
Recurrent node-positive breast cancer reveals distant metastasis in patients
12 Feb 2022No benefit to adding 5-ASAs to steroids in acute severe UC
11 Feb 2022
byRoshini Claire Anthony
The addition of 5-aminosalicylic acid (5-ASA) to standard corticosteroid treatment did not improve outcomes in patients hospitalized with acute severe ulcerative colitis (UC), according to a study presented at the Crohn’s and Colitis Congress 2022.